A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

The U.S. Food and Drug Administration said on Monday it will not take action against compounding pharmacies making copies of ...

Wegovy contains the same main ingredient as Ozempic, semaglutide, and is FDA-approved for weight loss in people with obesity or who are overweight with at least one weight-related condition. It is ...

Compounded versions of popular drugs used for weight loss including Wegovy and Zepbound will soon no longer be available ...

Very few people are currently being prescribed drugs for weight loss on the NHS in Scotland, research by BBC Scotland News ...

Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their ...

After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...

Some commercially insured patients stand to save $150 per month on Wegovy, a popular obesity medication. Patients on Medicare ...

After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight ...

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...

The weight-loss drug market is evolving at a rapid speed, with leading pharma companies including Novo Nordisk and Eli Lilly ...

Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.